Lactose (India) Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing, trading and carrying out job work and manufacturing of pharmaceutical products. The Company specializes in the manufacturing of excipients (lactose/liquid color coatings), lactulose, solid dosage forms and liquid dosage forms. It specializes in manufacturing of lactose monohydrate IP/BP/EP/USP-NF grades. The Company’s lactose products include Formulac 200M, Formulac 80M, Formulac 100M, Formulac 325M, Formulac DC60, Formulac 450M, Formulac 314M and Formulac DC2050. It is also engaged in the manufacturing of disaccharide lactulose, a versatile bulk API. Disaccharide Lactulose (galacto-fructose) is synthesized from lactose (galacto-glucose) by isomerization of glucose to fructose. Lactulose is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, chronic liver disease and as an effective prebiotic.As of 25 May 2026, LACTOSE (INDIA) LTD. share price is ₹121.50. The stock opened at ₹122.05, compared to its previous close of ₹121.35. During today's trading session, LACTOSE (INDIA) LTD. share price moved in the range of ₹115.45 to ₹125.00, with an average price of ₹120.22 for the day. Looking at its last 52-week, the stock has touched a low of ₹115.45 and a high of ₹125.00.
The market capitalization of LACTOSE (INDIA) LTD. is ₹153 Crs, with a P/E ratio of 25.2 and a dividend yield of 0.00%.